Posts for Grace Therapeutics, Inc. ($GRCE)

Discover Grace Therapeutics' amended Q3 2024 report, detailing compliance, stock info, and financial performance.

Explore Grace Therapeutics, Inc.'s Form 8-K filing detailing critical updates for investors. Key info on stock (GRCE) and significant corporate events on February 13, 2025.

Explore Grace Therapeutics, Inc.'s Q4 2024 financial report detailing operational losses, strategic R&D investments, and recent funding efforts. A crucial read for GRCE investors.

Discover key insights from Grace Therapeutics, Inc.'s 8-K filing, detailing significant events for investors. Stay informed on GRCE's latest corporate developments.